Company profile for National Cancer Institute

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

The National Cancer Institute (NCI) is part of the National Institutes of Health (NIH), which is one of 11 agencies that compose the Department of Health and Human Services (HHS). The NCI, established under the National Cancer Institute Act of 1937, is the Federal Government's principal agency for cancer research and training. The National Cancer Act of 1971 broadened the scope and responsibilities of the NCI and created the N...
The National Cancer Institute (NCI) is part of the National Institutes of Health (NIH), which is one of 11 agencies that compose the Department of Health and Human Services (HHS). The NCI, established under the National Cancer Institute Act of 1937, is the Federal Government's principal agency for cancer research and training. The National Cancer Act of 1971 broadened the scope and responsibilities of the NCI and created the National Cancer Program. Over the years, legislative amendments have maintained the NCI authorities and responsibilities and added new information dissemination mandates as well as a requirement.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
Bethesda, MD
Telephone
Telephone
1-800-422-6237
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.fiercebiotech.com/biotech/nci-axes-funding-pediatric-brain-cancer-trial-consortium-shifts-focus-broader-oncology

FIERCE BIOTECH
26 Aug 2025

https://www.fiercebiotech.com/biotech/250-more-nih-workers-laid-including-cuts-national-cancer-institute

FIERCE BIOTECH
06 May 2025

https://www.globenewswire.com/news-release/2025/03/13/3042134/37149/en/PDS-Biotech-Announces-FDA-Clearance-of-IND-Application-for-Combination-of-Versamune-MUC1-and-PDS01ADC-to-Treat-Metastatic-Colorectal-Cancer.html

GLOBENEWSWIRE
13 Mar 2025

https://www.businesswire.com/news/home/20241112194263/en

BUSINESSWIRE
12 Nov 2024

https://www.businesswire.com/news/home/20241029684934/en

BUSINESSWIRE
29 Oct 2024

https://www.prnewswire.com/news-releases/us-fda-issues-study-may-proceed-letter-for-the-pilot-study-of-pidnarulex-pharmacodynamics-in-patients-with-advanced-solid-tumors-sponsored-by-the-us-national-cancer-institute-302274665.html

PR NEWSWIRE
14 Oct 2024

ABOUT THIS PAGE

Contact National Cancer Institute and get a quotation

National Cancer Institute is a supplier offers 3 products (APIs, Excipients or Intermediates).

Find a price of Bevacizumab+Rituximab bulk offered by National Cancer Institute

Find a price of 2-CYANO-3, 12-DIOXOOLEANA-1, 9(11)-DIEN-28-OIC ACID (CDDO) bulk offered by National Cancer Institute

Find a price of HUMANIZED MIK-BETA-1 MONOCLONAL ANTIBODY bulk offered by National Cancer Institute

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty